SFCM
ENTX icon

Seven Fleet Capital Management’s Entera Bio ENTX Stock Holding History

Seven Fleet Capital Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
205,542
+70,224
+52% +$98.5K 0.07% 102
2025
Q4 		$263K Buy
+135,318
New +$317K 0.18% 61

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Seven Fleet Capital Management's ENTX Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Entera Bio (ENTX) stake by 52% in Q1 2026, buying an estimated $98.5K and bringing the position to 205,542 shares worth $228K. The position accounts for 0.07% of the portfolio, ranked #102.

Seven Fleet Capital Management first reported a position in ENTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $263K in Q4 2025. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • Seven Fleet Capital Management held 205,542 shares of Entera Bio worth $228K as of Q1 2026.
  • Seven Fleet Capital Management bought 70,224 Entera Bio shares in Q1 2026, an estimated $98.5K.
  • Entera Bio made up 0.07% of Seven Fleet Capital Management's portfolio in Q1 2026, its #102 holding.
  • Seven Fleet Capital Management first reported a position in Entera Bio in Q4 2025 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Entera Bio position peaked at $263K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.